Acurx Pharmaceuticals Inc - Nakit Akışı (NASDAQ:ACXP) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -5.01 M-7.54 M-9.8 M-10.38 M-6.79 M -6.79 M Yatırım faaliyetlerinden elde edilen nakit ————— — Finansman faaliyetlerinden elde edilen nakit 14.8 M3.7 M8.16 M6.62 M10.64 M 10.64 M Serbest nakit akışı -5.01 M-7.54 M-9.8 M-10.38 M-6.79 M -6.79 M

Haberler

Acurx Pharmaceuticals 2,5 milyon dolarlık finansman turunu kapattı

Acurx Pharmaceuticals doğrudan arzda 2,5 milyon dolar topladı

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript

Acurx Pharmaceuticals 4Ç 2025 sonuçları: Nakit artışı ve Ar-Ge ilerlemesi

Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress

Acurx Pharmaceuticals hisseleri yeni rCDI denemesiyle %3 kazandı

Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch

What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)